| XLS |
|
Merck Group | Key figures | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ million |
Q3 2012 |
Q3 2011 |
Change |
Jan.–Sept. 2012 |
Jan.–Sept. 2011 |
Change |
|
Total revenues |
2,841.0 |
2,531.6 |
12.2% |
8,338.1 |
7,650.7 |
9.0% |
|
Sales |
2,721.7 |
2,434.3 |
11.8% |
8,028.7 |
7,381.4 |
8.8% |
|
Operating result (EBIT) |
318.1 |
331.8 |
–4.1% |
651.9 |
836.4 |
–22.1% |
|
Margin (% of sales) |
11.7% |
13.6% |
|
8.1% |
11.3% |
|
|
EBITDA |
661.0 |
646.3 |
2.3% |
1,689.4 |
2,090.8 |
–19.2% |
|
Margin (% of sales) |
24.3% |
26.5% |
|
21.0% |
28.3% |
|
|
EBITDA pre one-time items |
754.2 |
652.5 |
15.6% |
2,175.1 |
2,043.2 |
6.5% |
|
Margin (% of sales) |
27.7% |
26.8% |
|
27.1% |
27.7% |
|
|
EPS pre one-time items (€) |
1.98 |
1.62 |
22.2% |
5.56 |
5.12 |
8.6% |
|
Free cash flow |
814.8 |
481.5 |
69.2% |
1,860.2 |
1,380.1 |
34.8% |